COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulation

Published:2022-07 Issue:3 Volume:13 Page:100632
ISSN:0975-9476
Container-title:Journal of Ayurveda and Integrative Medicine
language:en
Short-container-title:Journal of Ayurveda and Integrative Medicine

Author:

Dilip Pandkar Prasad^ORCID,Deshmukh Santosh Raosaheb,Sachdeva Vinay^ORCID

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery

Reference35 articles.

1. The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19;Anil;Lancet Oncol,2020

2. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study;Kuderer;Lancet,2020

3. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study;Lamure;EClinicalMedicine,2020

4. Ayurvedic clinical profile of COVID-19 – a preliminary report;Puthiyedath;J Ayurveda Integr Med,2020

5. Efficacy of Madhav rasayan plus as adjuvant in moderate COVID-19 patients: preliminary outcomes of randomized controlled trial;Jamadagni;J Ayurveda Integr Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP